BEAM
Price
$17.56
Change
-$0.30 (-1.68%)
Updated
Aug 8, 12:40 PM (EDT)
Capitalization
1.81B
94 days until earnings call
OVID
Price
$0.51
Change
-$0.00 (-0.00%)
Updated
Aug 8, 10:43 AM (EDT)
Capitalization
36.37M
10 days until earnings call
Interact to see
Advertisement

BEAM vs OVID

Header iconBEAM vs OVID Comparison
Open Charts BEAM vs OVIDBanner chart's image
Beam Therapeutics
Price$17.56
Change-$0.30 (-1.68%)
Volume$1.68K
Capitalization1.81B
Ovid Therapeutics
Price$0.51
Change-$0.00 (-0.00%)
Volume$2.99K
Capitalization36.37M
BEAM vs OVID Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. OVID commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and OVID is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BEAM: $17.86 vs. OVID: $0.51)
Brand notoriety: BEAM and OVID are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. OVID: 21%
Market capitalization -- BEAM: $1.81B vs. OVID: $36.37M
BEAM [@Biotechnology] is valued at $1.81B. OVID’s [@Biotechnology] market capitalization is $36.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileOVID’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • OVID’s FA Score: 1 green, 4 red.
According to our system of comparison, OVID is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while OVID’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • OVID’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both BEAM and OVID are a bad buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а -9.39% price change this week, while OVID (@Biotechnology) price change was +2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.02%. For the same industry, the average monthly price growth was +6.41%, and the average quarterly price growth was +12.32%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

OVID is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+0.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.81B) has a higher market cap than OVID($36.4M). BEAM YTD gains are higher at: -27.984 vs. OVID (-45.218). OVID has higher annual earnings (EBITDA): -56.4M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. OVID (43M). OVID has less debt than BEAM: OVID (14.4M) vs BEAM (158M). BEAM has higher revenues than OVID: BEAM (63.6M) vs OVID (548K).
BEAMOVIDBEAM / OVID
Capitalization1.81B36.4M4,964%
EBITDA-399.03M-56.4M708%
Gain YTD-27.984-45.21862%
P/E RatioN/AN/A-
Revenue63.6M548K11,606%
Total Cash1.22B43M2,837%
Total Debt158M14.4M1,097%
FUNDAMENTALS RATINGS
OVID: Fundamental Ratings
OVID
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMOVID
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 17 days ago
79%
Bullish Trend 1 day ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JEGRX17.690.11
+0.63%
Janus Henderson Global Sust Eq R
PRMTX169.03N/A
N/A
T. Rowe Price Comm & Tech Investor
HGHYX39.57N/A
N/A
Hartford Healthcare Y
SUVQX12.89N/A
N/A
PGIM Quant Solutions Large-Cap Val R6
APHRX35.35-0.11
-0.31%
Artisan Global Opportunities Instl

OVID and

Correlation & Price change

A.I.dvisor indicates that over the last year, OVID has been closely correlated with JBIO. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if OVID jumps, then JBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVID
1D Price
Change %
OVID100%
+0.25%
JBIO - OVID
79%
Closely correlated
-6.51%
ABOS - OVID
46%
Loosely correlated
+4.41%
RXRX - OVID
44%
Loosely correlated
-1.28%
BEAM - OVID
44%
Loosely correlated
-2.40%
CCCC - OVID
42%
Loosely correlated
+31.63%
More